Europe Digital Health Market to Reach USD 314.32 Billion by 2034, Growing at a CAGR of 10.27%

The Europe digital health market is experiencing robust growth, driven by accelerated digital transformation across national health systems, the European Health Data Space (EHDS) regulatory rollout, demographic pressure from an aging EU population, AI-enabled clinical workflows, and rising consumer adoption of telehealth, wearables, and remote monitoring platforms. The market size increased from USD 130.37 Billion in 2025 to USD 143.78 Billion in 2026 and is projected to reach USD 314.32 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.27% during 2026-2034.

Digital health refers to the use of information and communication technologies (ICTs) to improve disease prevention, diagnosis, treatment, monitoring, and health system management. Europe's digital health market spans telehealth and telemedicine platforms, mobile health (mHealth) applications, electronic health records (EHR/EMR), medical wearables and remote patient monitoring (RPM) devices, healthcare data analytics, and AI-driven diagnostic and decision-support tools.

Rising demand for telemedicine, remote patient monitoring, electronic health records, mobile health applications, and AI-enabled diagnostics is being supported by aging populations, increasing chronic disease burden, and the need to reduce pressure on hospitals and clinics. Strong government focus on healthcare digitization, cross-border health data exchange, and connected care infrastructure is further encouraging investment in digital platforms. In addition, the expansion of wearable devices, cloud-based healthcare systems, and personalized medicine is transforming how patients, providers, and payers interact across the European healthcare ecosystem.

Request a Sample Report for In-Depth Market Insights: https://www.imarcgroup.com/europe-digital-health-market/requestsample

Europe Digital Health Market Summary

• Covers digital health solutions by type (telehealth, medical wearables, EMR/EHR systems, medical apps, healthcare analytics, others), component (software, hardware, service), and country (Germany, France, United Kingdom, Italy, Spain, and other European markets).
• The European Health Data Space (EHDS) Regulation, published in 2025, is a dominant regulatory theme, aiming to enhance access, interoperability, and innovative use of electronic health data across member states. National systems are scaling digital infrastructure to address aging populations, workforce shortages, and rising healthcare costs.
• AI integration is accelerating across diagnostics, clinical decision support, and predictive analytics. In October 2025, the European Commission launched the EUR 1 Billion Apply AI strategy funding AI-powered screening centers. The EU AI Act, effective August 2024 with phased application through 2027, sets requirements for high-risk medical AI systems.
• Cross-border digital health M&A and platform consolidation are intensifying, exemplified by Hims & Hers' June 2025 acquisition of UK-based ZAVA, and Doctolib's May 2026 acquisition of UK-based Medicus Health.
• Reimbursement pathway fragmentation across member states—Germany's DiGA, France's PECAN, and the UK's NICE evidence framework—poses challenges for vendor speed-to-market across Europe.

PORTER'S FIVE FORCES ANALYSIS – Europe Digital Health Market

The competitive dynamics of the Europe Digital Health Market can be analyzed using Porter's Five Forces framework.

Porter's Five Forces Analysis – Europe Digital Health Market

• Competitive Rivalry: High, characterized by intense competition among established global medical technology companies, regional specialists, and emerging digital health startups. The market is structurally fragmented at the application layer, with the top five vendors—Siemens, Koninklijke Philips N.V., Medtronic, Oracle, and Epic Systems Corporation—collectively controlling under 20% of total revenue. Rivalry is driven by the need for technological innovation, regulatory compliance expertise, hospital relationships, and multi-country framework agreements. Business implication: Competitors must differentiate through AI-enabled diagnostic platforms, EHDS-aligned interoperability, plug-in licensing models reducing TCO, and strong after-sales support to win market share.
• Supplier Power (Component and Technology Providers): Moderate. While large digital health vendors have significant bargaining power over component suppliers, providers of advanced technology—including cloud infrastructure (AWS, Microsoft Azure, Google Cloud), AI hardware and chip manufacturers, semiconductor suppliers, and cybersecurity vendors—hold increasing influence as digital health infrastructure becomes critical. The push for AI-powered diagnostics and connected care solutions also gives specialized technology suppliers an edge. Business implication: Digital health vendors must form strategic partnerships with technology firms or develop in-house capabilities to secure critical components and maintain competitive advantage.
• Buyer Power (Healthcare Providers and Payers): Moderate to High, particularly for national health services and large hospital networks that purchase in bulk. These buyers have significant negotiating power and can demand favorable pricing, integration support, and evidence of clinical efficacy. National statutory healthcare schemes and country-specific digital health reimbursement frameworks exert considerable influence over market access. However, smaller clinics and individual practitioners often have less power, particularly when seeking access to subsidized digital health solutions. Business implication: Manufacturers need to offer flexible pricing models, strong integration support, and solutions tailored to diverse healthcare provider sizes and specialty needs.
• Threat of Substitutes: Low to Moderate. The primary substitute for digital health solutions is traditional in-person care delivery, which remains the standard for many clinical interactions. However, this is increasingly uneconomical due to rising healthcare costs, workforce shortages, and patient demand for accessible, data-driven services. In some contexts, legacy IT systems and paper-based records can still substitute for digital health platforms, but this is increasingly untenable due to EHDS interoperability mandates and regulatory pressure. Business implication: To counter the traditional care threat, digital health vendors can focus on offering advanced technology (AI diagnostics, RPM, telehealth) and service packages that provide clear productivity and clinical outcome advantages over conventional models.
• Threat of New Entrants: Moderate. High barriers exist for large-scale platform development due to the need for significant capital investment, regulatory compliance (GDPR, EU AI Act, MDR), established hospital relationships, and strong brand reputation. However, barriers are lower for niche specialists, technology providers, or developers of specific digital health applications. The region's growth, government support (Apply AI funding, EU4Health contracts), and reimbursement frameworks attract new domestic and international entrants, especially from the US and Asia, offering competitively priced alternatives. Business implication: Established players should build defensible positions through technological leadership, exclusive access to reimbursement schemes, and strong relationships with national health services and key healthcare distributors.

MARKET GROWTH DRIVERS

Aging Population and Rising Chronic Disease Burden

Europe holds one of the world's oldest demographic profiles, with approximately one-fifth of the EU population aged 65 or older as of early 2025. Remote patient monitoring (RPM), telehealth consultations, and digital therapeutics enable proactive intervention and continuous care for chronic-disease patients, reducing acute episodes and hospitalizations. The increasing prevalence of chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders is driving demand for continuous monitoring and digital management solutions.

Government Support and EHDS Regulatory Advancement

Germany's DiGA framework allows certified digital health apps to be prescribed and reimbursed under statutory healthcare. France's PECAN fast-track reimburses evidence-based apps after review (up to 60 days). Italy's EUR 15.6 Billion healthcare mission covers community care, telemedicine, and digitalization under the National Recovery and Resilience Plan (2021–2026). In November 2025, the European Health and Digital Executive Agency (HaDEA) signed new EU4Health contracts to strengthen the EHDS and help stakeholders comply with secondary-use data requirements.

AI and Cloud Integration in Clinical Workflows

In October 2025, the European Commission launched the EUR 1 Billion Apply AI strategy funding AI-powered screening centers. Siemens, Koninklijke Philips N.V., and Oracle are embedding AI diagnostic modules, predictive analytics, and population health tools into EHR and imaging platforms, accelerating multi-country deployments. Cloud-native EHR and clinical platforms anchor digital health infrastructure across Europe, with Koninklijke Philips N.V. expanding its radiology informatics cloud on AWS to European data centers in February 2025.

Healthcare Workforce Constraints Driving Automation

A 2025 survey of 442 healthcare executives across 13 European countries found severe staffing shortages, with 90% of German hospitals affected. Digital scheduling, RPM, virtual care, and AI-assisted documentation enable redistribution of clinical workload across teams, supporting service continuity amid demographic pressure. The need to do more with fewer resources is a fundamental driver of digital health adoption across the region.

Rising Consumer Adoption of Telehealth and Wearables

Permanent reimbursement codes, clinician familiarity with video workflows, and continued post-pandemic adoption are driving telehealth uptake. The European telehealth segment alone was valued at USD 36.5 Billion in 2025 and is projected to reach approximately USD 88 Billion by 2034. Medical wearables at 19.6% and EMR/EHR systems at 17.8% form the next-largest type segments, with Germany's DiGA framework enabling reimbursable "apps on prescription."

EUROPE DIGITAL HEALTH MARKET SEGMENTATION

Type Insights:

• Telehealth
• Medical Wearables
• EMR/EHR Systems
• Medical Apps
• Healthcare Analytics
• Others

Component Insights:

• Software
• Hardware
• Service

Country Insights:

• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

COMPETITIVE LANDSCAPE

The Europe digital health market features a structurally fragmented competitive landscape at the application layer, with the top five vendors collectively controlling under 20% of total revenue. Leading players include Siemens, Koninklijke Philips N.V., Medtronic, Oracle, and Epic Systems Corporation. These established players lead the enterprise segment through scale, regulatory expertise, and hospital relationships. Regional specialists Doctolib, Doccla, and Ada Health anchor the country-specific layer, with Doctolib leveraging local reimbursement frameworks. Cloud infrastructure providers (AWS, Microsoft Azure, Google Cloud) are emerging as adjacent competitors, offering scalable healthcare services. M&A activity is intensifying, exemplified by Hims & Hers' June 2025 acquisition of ZAVA.

Key players include:

• Siemens
• Koninklijke Philips N.V.
• Medtronic
• Oracle
• Epic Systems Corporation

REGIONAL ANALYSIS

United Kingdom

The United Kingdom leads at 26.0% in 2025, anchored by the NHS Long Term Plan digital transformation, sustained UK health-tech venture capital flows, and the concentration of innovation hubs across London, Cambridge, and Oxford. Post-Brexit regulatory autonomy enables flexible approaches to new digital health technologies while maintaining alignment with international safety standards. London-based Doccla raised GBP 35 Million in September 2024 to scale RPM across the UK and Europe.

Germany

Germany at 21.8% remains the second-largest market, anchored by plans to invest around EUR 2 billion in a national healthcare cybersecurity program running until 2029 to strengthen the resilience of hospitals and critical health infrastructure. The country's DiGA framework allows certified digital health apps to be prescribed and reimbursed under statutory healthcare. German hospitals received EUR 300 Million in government allocation for EHR and cybersecurity upgrades. Siemens Healthineers, headquartered in Germany, is a leading global medical technology company and one of Europe's most influential digital health vendors.

France

France at 18.6% leads telehealth adoption with PECAN fast-track and Doctolib's e-prescribing expansion. The country's PECAN fast-track reimburses evidence-based apps after review (up to 60 days). France's strong domestic telehealth platform leadership and national e-prescription rollout are key growth drivers.

Italy

Italy at 13.7% benefits from a multi-billion-euro community-care digitalization plan, widespread local health hub deployment, and EU recovery fund-supported initiatives. Italy's EUR 15.6 Billion healthcare mission covers community care, telemedicine, and digitalization under the National Recovery and Resilience Plan (2021–2026).

Spain

Spain at 10.9% is experiencing growing telehealth adoption across regions, with public-private partnerships strengthening regional health systems. The country's focus on renewable energy infrastructure and digital health integration supports market growth.

Others

The Others category at 9.0% includes the Netherlands with near-universal electronic health record adoption and Nordic states advancing cross-border health data exchange. Eastern European and Nordic markets present substantial growth headroom as EU recovery and structural funds accelerate national digital health investments.

RECENT INDUSTRY DEVELOPMENTS

October 2025: The European Commission launched a EUR 1 Billion Apply AI strategy funding AI-powered screening centers for early disease detection across the bloc.

November 2025: The European Health and Digital Executive Agency (HaDEA) signed new EU4Health contracts to strengthen the EHDS and help stakeholders comply with secondary-use data requirements.

June 2025: Hims & Hers entered the European market via its acquisition of UK-based ZAVA, signaling intensifying cross-border M&A across dermatology, mental health, and weight loss.

May 2026: Doctolib acquired UK-based Medicus Health to enter the UK digital health market.

February 2025: Koninklijke Philips N.V. expanded its radiology informatics cloud on AWS to European data centers, enabling remote diagnostic reading with AI post-processing.

December 2024: Siemens Healthineers unveiled Luminos Q.namix, a fluoroscopy and radiography platform with AI-guided workflows.

September 2024: London-based Doccla raised GBP 35 Million to expand RPM across the UK and Europe, enabling 24/7 patient tracking and reducing emergency admissions.

April 2024: OMRON Healthcare Co., Ltd. acquired Luscii Healthtech, whose multi-condition RPM software is deployed in 70% of the Netherlands' hospitals.

Request Customization: https://www.imarcgroup.com/request?type=report&id=10917&flag=E

Report Format, Delivery, and Customization Details

• Report Format Mode: PPT, PDF, and Excel
• Report Delivery Mode: Online Delivery, Physical Delivery
• Report Delivery Time: Report Delivered Over Email within 24 to 48 hours. If requested by the client, a physical copy will be delivered within three to ten days.
• Report Confirmation Mode: Yes via Email
• Report Customization Mode: Yes via Email / Call
• Report Table of Content: Yes
• Report List of Figures: Yes
• Report Methodology Mode: Yes
• Request For Sample Report: Yes

Contact Us

IMARC Group

134 N 4th St., Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.